Back for the month of June are the editors’ picks from the eight scientific journals published by the American Association for Cancer Research (AACR). Selections this month range from the identification of a long...
Irene Ghobrial, MD, a medical oncologist, answer questions from the Cancer Today staff on a study of precursor conditions to multiple myeloma. March is Multiple Myeloma Awareness Month.
In the past year, the number of American teenagers using tobacco products has increased by nearly 40 percent, reversing a trend that public health officials worked tirelessly to achieve. The primary culprit in the resurgence...
A recent estimate suggests that more than 40 percent of cancers could be prevented. Modifiable factors linked to cancer include tobacco use, obesity, alcohol consumption, and exposure to environmental carcinogens, which are substances in...
The tobacco product landscape is evolving and the AACR Tobacco Products and Cancer Subcommittee has been cognizant of the shift from combusted products (e.g., cigarettes) to alternative nicotine delivery systems, such as e-cigarettes. While...
Metastasis is defined as the spreading of cancer cells from the place where they first formed to another part of the body. Once cancer has metastasized, it can become more difficult to treat, increasing...
On Saturday, May 4, Philadelphians flooded the Benjamin Franklin Parkway for the Franklin Institute’s ninth annual Philadelphia Science Festival. For the fourth consecutive year, the American Association for Cancer Research (AACR) was a sponsor...
Since the 1990s, the cancer mortality rate in the U.S. has steadily declined. Yet liver cancer death rates in the U.S. have increased. Why? Liver cancer is caused principally by the combination of a chronic...
A large study of postmenopausal women showed strong benefit from smoking cessation in lowering the risk of bladder cancer. Bladder cancer is the most common malignancy of the urinary system. Some 80,470 new diagnoses...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased the number of treatment options for certain patients with bladder, lung, and kidney cancer. On...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More